Responses of blood lipids and lipoproteins to extended-release niacin and exercise in sedentary postmenopausal women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 9, 2010, Pages 924-932

  Koh, Yunsuk ^a   Ben Ezra, Vic ^b   Biggerstaff, Kyle D ^b   Nichols, David L ^b  

^a LAMAR UNIVERSITY   (United States)

^b TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

Blood lipids and lipoproteins; Exercise; Niaspan; Postmenopausal women

Indexed keywords

ANTILIPEMIC AGENT; LIPID; LIPOPROTEIN; NICOTINIC ACID;

ARTICLE; BLOOD; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; EXERCISE; FEMALE; HUMAN; MIDDLE AGED; POSTMENOPAUSE; SEDENTARY LIFESTYLE;

ANTILIPEMIC AGENTS; DELAYED-ACTION PREPARATIONS; EXERCISE; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MIDDLE AGED; NIACIN; POSTMENOPAUSE; SEDENTARY LIFESTYLE;

EID: 77955857660     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq097     Document Type: Article

References (61)

1. Lloyd-Jones D, adams R, Carnethon M, et al. Heart disease and stroke statistics\2009 update: A report from the american Heart association statistics Committee and stroke statistics subcommittee. Circulation. 2009;119(3):480-486.
2. Asikainen TM, Kukkonen-Harjula K, Miilunpalo s. Exercise for health for early postmenopausal women: A systematic review of randomised controlled trials. Sports Med. 2004;34(11):753-778.
3. Binder EF, Birge SJ, Kohrt WM. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women. J Am Geriatr Soc. 1996;44:231-236.
4. National Cholesterol Education Program. Executive summary of The Third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in adults (adult Treatment Panel iii). JAMA 2001, 285, 19, 2486-2497.
5. Shepherd J, Betteridge J, van Gaal l. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: A position paper developed by a European Consensus Panel. Curr Med Res Opin. 2005;21(5):665-682.
6. Blumenthal JA, Matthews K, Fredrikson M, et al. Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women. Arterioscler Thromb. 1991;11(4):912-917.
7. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing rr. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321(10):641-646.
8. Sowers MR, la Pietra MT. Menopause: Its epidemiology and potential association with chronic diseases. Epidemiol Rev. 1995;17(2): 287-302.
9. Durstine JL, Grandjean PW, Cox CA, Thompson Pd. lipids, lipopro-teins, and exercise. J Cardiopulm Rehabil. 2002;22(6):385-398.
10. Kelley GA, Kelley KS, Franklin B. aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: A meta-analysis of randomized controlled trials. J Cardiopulm Rehabil. 2006;26:131-139.
11. Alhassan S, reese KA, Mahurin J, et al. Blood lipid responses to plant stanol ester supplementation and aerobic exercise training. Metabolism. 2006;55(4):541-549.
12. Crouse SF, o'Brien BC, Grandjean PW, lowe RC, rohack JJ, Green Js. Effects of training and a single session of exercise on lipids and apolipoproteins in hypercholesterolemic men. J Appl Physiol. 1997;83: 2019-2028.
13. Bermingham MA, Mahajan D, Neaverson Ma. Blood lipids of cardiac patients after acute exercise on land and in water. Arch Phys Med Rehabil. 2004;85(3):509-511.
14. Grandjean PW, Crouse SF, rohack JJ. infuence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise. J Appl Physiol. 2000;89(2):472-480.
15. Weise SD, Grandjean PW, rohack JJ, Womack JW, Crouse sF. acute changes in blood lipids and enzymes in postmenopausal women after exercise. J Appl Physiol. 2005;99(2):609-615.
16. Imamura H, Katagiri S, uchid K, Miyamoto N, Nakano H, shirota T. acute effects of moderate exercise on serum lipids, lipoproteins and apolipoproteins in sedentary young women. Clin Exp Pharmacol Physiol. 2000;27(12):975-979.
17. Williams PT, stefanick ML, vranizan KM, Wood Pd. The effects of weight loss by exercise or by dieting on plasma high-density lipopro-tein (Hdl) levels in men with low, intermediate, and normal-to-high Hdl at baseline. Metabolism. 1994;43(7):917-924.
18. Kelley GA, Kelley KS, Tran Zv. aerobic exercise and lipids and lipo-proteins in women: A meta-analysis of randomized controlled trials. J Womens health (Larchmt). 2004;13(10):1148-1164.
19. Pieper Ja. overview of niacin formulations: differences in pharma-cokinetics, effcacy, and safety. Am J health Syst Pharm. 2003; 60(13 suppl 2):s9-s14.
20. Knopp RH, alagona P, davidson M, et al. Equivalent effcacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism. 1998;47(9): 1097-1104.
21. Piepho rW. The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. Am J Cardiol. 2000;86(12a):35l-40l.
22. Altschul R, Hoffer A, stephen Jd. infuence of nicotinic acid on serum cholesterol in man. Arch Biochem. 1955;54(2):558-559.
23. Goldberg A, alagona P JR, Capuzzi DM, et al. Multiple-dose effcacy and safety of an extended-release form of niacin in the management of hyperlipidemia. Am J Cardiol. 2000;85(9):1100-1105.
24. Grundy SM, Mok HY, Zech L, Berman M. infuence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res. 1981;22(1):24-36.
25. Knopp RH, Ginsberg J, albers JJ, et al. Contrasting effects of unmodifed and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism. 1985; 34(7):642-650.
26. Snyder s. Comparison of cholesterol-lowering regimens. Am Fam Physician. 1990;42(3):761-768.
27. Wang W, Basinger A, Neese RA, Christiansen M, Hellerstein MK. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab. 2000;279(1):E50-E59.
28. Goldberg aC. Clinical trial experience with extended-release nia-cin (Niaspan): dose-escalation study. Am J Cardiol. 1998;82(12a): 35u-38u.
29. Goldberg aC. a meta-analysis of randomized controlled studies on the effects of extended-release niacin in women. Am J Cardiol. 2004;94(1):121-124.
30. Durstine JL, Crouse SF, Moffatt rJ. lipids in exercise and sports. in: driskell JA, Wolinsky I, eds. Energy Yielding Macronutrients and Energy Metabolism in Sports Nutrition. Boca raton, Fl: CrC press; 2000:87-117.
31. Ganji SH, Tavintharan S, Zhu D, Xing Y, Kamanna VS, Kashyap Ml. Niacin noncompetitively inhibits dGaT2 but not dGaT1 activity in HepG2 cells. J Lipid Res. 2004;45(10):1835-1845.
32. Zhang JQ, smith B, langdon MM, et al. Changes in lPla and reverse cholesterol transport variables during 24-h postexercise period. Am J Physiol Endocrinol Metab. 2002;283(2):E267-E274.
33. Zhang Y, schmidt RJ, Foxworthy P, et al. Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74a. Biochem Biophys Res Commun. 2005;334(2):729-732.
34. Karpe F, Frayn KN. The nicotinic acid receptor\a new mechanism for an old drug. Lancet. 2004;363(9424):1892-1894.
35. Ganji SH, Kamanna VS, Kashyap Ml. Niacin and cholesterol: Role in cardiovascular disease (review). J Nutr Biochem. 2003;14(6):298-305.
36. Jin FY, Kamanna VS, Kashyap Ml. Niacin decreases removal of high-density lipoprotein apolipoprotein a-i but not cholesterol ester by Hep G2 cells. implication for reverse cholesterol transport. Arterioscler Thromb Vasc Biol. 1997;17(10):2020-2028.
37. Sprecher dl. raising high-density lipoprotein cholesterol with niacin and fbrates: A comparative review. Am J Cardiol. 2000;86(12a): 46l-50l.
38. Lewis GF, rader dJ. New insights into the regulation of Hdl metabolism and reverse cholesterol transport. Circ Res. 2005;96(12):1221-1232.
39. Whelan AM, Price SO, Fowler SF, Hainer Bl. The effect of aspirin on niacin-induced cutaneous reactions. J Fam Pract. 1992;34(2): 165-168.
40. Armstrong L, Balady GJ, Berry MJ, et al. ACSM's Guidelines for Exercise Testing and Prescription. 7th ed. Baltimore, Md: lippincott Williams & Wilkins; 2006.
41. Mcardle WD, Katch FI, Katch vl. Sports & Exercise Nutrition. Baltimore, Md: Williams & Wilkins; 1999.
42. Wedding ME, Toenjes sa. Medical Laboratory Procedures, 2nd ed. Philadelphia, Pa: F.a. davis Company; 1998.
43. Drabkin OL, austin JH. spectrophotometric studies ii. Preparation from washed cells; nitric oxide, hemoglobin, and sulfhemoglobin. J Biol Chem. 1935;112:51-55.
44. Dill DB, Costill dl. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol. 1974; 37(2):247-248.
45. Friedewald WT, levy RI, Fredrickson ds. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
46. Pan J, van JT, Chan E, Kesala RL, lin M, Charles Ma. Extended-release niacin treatment of the atherogenic lipid profle and lipoprotein(a) in diabetes. Metabolism. 2002;51(9):1120-1127.
47. Sakai T, Kamanna VS, Kashyap Ml. Niacin, but not gemfbrozil, selectively increases lP-ai, a cardioprotective subfraction of Hdl, in patients with low Hdl cholesterol. Arterioscler Thromb Vasc Biol. 2001;21(11):1783-1789.
48. Plaisance EP, Mestek ML, Mahurin AJ, Taylor JK, Moncada-Jimenez J, Grandjean PW. Postprandial triglyceride responses to aerobic exercise and extended-release niacin. Am J Clin Nutr. 2008;88(1):30-37.
49. Capuzzi DM, Guyton JR, Morgan JM, et al. Effcacy and safety of an extended-release niacin (Niaspan): A long-term study. Am J Cardiol. 1998;82(12a):74u-81u.
50. Guyton JR, Goldberg AC, Kreisberg RA, sprecher DL, superko HR, o'Connor CM. Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol. 1998;82(6):737-743.
51. Guyton JR, Capuzzi dM. Treatment of hyperlipidemia with combined niacin-statin regimens. Am J Cardiol. 1998;82(12a):82u-84u.
52. Kushinick rM. Lipid and Lipoprotein Metabolism in Response to Treadmill Walking at Two Levels of Caloric Expenditure: A Comparison of Black and White American Men [Dissertation]. Tallahassee, Fl: The Florida state university 2003.
53. Ferguson MA, alderson NL, Trost SG, Essig DA, Burke JR, durstine Jl. Effects of four different single exercise sessions on lipids, lipopro-teins, and lipoprotein lipase. J Appl Physiol. 1998;85(3):1169-1174.
54. Perreault L, lavely JM, Kittelson JM, Horton TJ. Gender differences in lipoprotein lipase activity after acute exercise. Obes Res. 2004; 12(2):241-249.
55. Ferguson MA, alderson NL, Trost SG, davis PG, Mosher PE, durstine Jl. Plasma lipid and lipoprotein responses during exercise. Scand J Clin Lab Invest. 2003;63:73-80.
56. Gordon PM, Fowler S, Warty V, danduran M, visich P, Keteyian s. Effects of acute exercise on high density lipoprotein cholesterol and high density lipoprotein subfractions in moderately trained females. Br J Sports Med. 1998;32(1):63-67.
57. Durstine JL, davis PG, Ferguson MA, alderson NL, Trost sG. Effects of short-duration and long-duration exercise on lipoprotein(a). Med Sci Sports Exerc. 2001;33(9):1511-1516.
58. Angelopoulos TJ, robertson RJ, Goss FL, Metz KF, laPorte rE. Effect of repeated exercise bouts on high density lipoprotein-cholesterol and its subfractions Hdl2-C and Hdl3-C. Int J Sports Med. 1993;14(4): 196-201.
59. Sgouraki E, Tsopanakis A, Tsopanakis C. acute exercise: Response of Hdl-C, ldl-C lipoproteins and Hdl-C subfractions levels in selected sport disciplines. J Sports Med Phys Fitness. 2001;41(3):386-391.
60. Attie AD, Kastelein JP, Hayden Mr. Pivotal role of aBCa1 in reverse cholesterol transport infuencing Hdl levels and susceptibility to atherosclerosis. J Lipid Res. 2001;42(11):1717-1726.
61. Kwiterovich Po Jr. The antiatherogenic role of high-density lipopro-tein cholesterol. Am J Cardiol. 1998;82(9a):13Q-21Q.